Found 19 matching trials
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer PHASE1 The goal of this clinical trial is to evaluate the efficacy and safety of c...
Show More Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Donafenib for Recurrent Cervical Cancer PHASE2 This study is to evaluate the safety and tolerability of Donafenib combined...
Show More Learn More & Join Trial
Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma PHASE2 The purpose of this study is to evaluate the safety and efficacy of Gecacit...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate PHASE1 To assess the safety and efficacy of third-line and above therapy of patien...
Show More Location
The First Affiliated Hospital of College of Medicine Zhejiang University
Learn More & Join Trial
Donafenib Plus Sintilimab for Advanced HCC PHASE2 This study will evaluate the efficacy and safety of donafenib combined with...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer PHASE2 This study is a single-arm intervention study. Locally advanced differentia...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world Study N/A This Retrospective Real-world study was designed to evaluate the clinical e...
Show More Location
Multiple Locations
Learn More & Join Trial
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion PHASE4 A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma N/A The aim of this study is to the efficacy, prognosis, adverse effects, and f...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial